Multimodal Exercise Program on Parkinson's Disease Patients With Depression
Trial
N/A
Completed
Nov. 25, 2018
Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.
Trial
Phase 2
Completed
Nov. 22, 2018
Gait Disorders in Parkinson's Disease
Trial
Early Phase 1
Withdrawn
Nov. 19, 2018
Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms
Trial
N/A
Completed
Nov. 18, 2018
Study on the Visual Condition in Parkinson's Disease
Trial
N/A
Unknown
Nov. 15, 2018
Rehabilitation of Postural Abnormalities in Parkinson's Disease
Trial
N/A
Unknown
Nov. 14, 2018
Modified Exercise Programme in Individuals With Parkinson's Disease
Trial
N/A
Completed
Nov. 14, 2018
Prismatic Lenses in the Pisa Syndrome
Trial
N/A
Completed
Nov. 12, 2018
The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease
Trial
N/A
Completed
Nov. 12, 2018
Dyskinesia in Parkinson's Disease (Study P04501)
Trial
Phase 2
Completed
Nov. 8, 2018
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
Trial
Phase 2
Completed
Nov. 7, 2018
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
Trial
Phase 1
Completed
Nov. 7, 2018
Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
Trial
Phase 1
Completed
Nov. 6, 2018
A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)
Trial
Phase 3
Terminated
Nov. 6, 2018
Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease
Trial
N/A
Completed
Nov. 5, 2018
A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)
Trial
Phase 3
Completed
Nov. 5, 2018
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
Trial
Phase 3
Terminated
Nov. 5, 2018
Protocol: Balance Training in Parkinson's Disease
Trial
N/A
Completed
Nov. 1, 2018
Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease
Trial
Phase 2
Withdrawn
Nov. 1, 2018